Download - Practice Guidelines
Practice Guidelines
The Good, The Not-So-Good The Ugly
1
Where do practice guidelines come from?
Trust us, we’re the experts: Opinion-based/ consensus guidelines• Whose opinion? Do they have a conflict of interest? What is
their perspective? Trust us, we have the evidence: “Evidence-
based”• How was the evidence used? Patient-oriented? Values?
Evidence-linked:• Here is how we found the evidence, used the evidence
• Strength of recommendation noted
Guidelines: Ultimately a social exercise
Evidence: It is what it is The human touch:
• Social judgment layered on top of the evidence
3
Breast Cancer Screening and the USPSTF
The Evidence
How They Arrived at these Conclusions
Meta-analysis of 8 randomized controlled trials (RCTs)• Invited a total of 348,219 women at age 40 yrs for
yearly screening
• 0-3 studies, individually, showed a decrease in breast cancer mortality
• Meta-analysis: Combining results from all trials and analyzing the results
• Results:
Figure. Nelson HD. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737.
Benefits10,000 women ages 40-49 yrs screened yearly
USPSTF Recommendation Statement. Ann Intern Med 2009;151(10):716-726
USPSTF Recommendation Grades, 2009
USPSTF Recommendation Statement: Breast Cancer Screening
Why Does The BenefitSeem To Be So Small?
Breast cancer mortality vs all causes of mortality, all ages
Black WC, et al. All-Cause Mortality in Randomized Trials of Cancer Screening. Journal of the National Cancer Institute, Vol. 94, No. 3, 167-173, February 6, 2002
Causes of death in women, by age
Bunker JP, Houghton J, Baum M. Putting the risk of breast cancer in perspective. BMJ 1998;317:1307-9.
But What About “1-in-8”?
Ave lifespan = 79 years
Bunker JP, et al. Putting the risk of breast cancer in perspective. BMJ 1998;317:1307-9.
Risks10,000 women ages 40-49 yrs screened yearly
USPSTF Recommendation Statement. Ann Intern Med 2009;151(10):716-726
Pseudodisease (overdiagnosis)
A condition that looks just like the disease, but never would have bothered the patient• Disease that would never cause symptoms
• Asymptomatic disease in people who will die from another cause before disease presents
An estimated 10%-30% of breast cancers found and treated would have never affected the patients• The question: which ones?
Cochrane Database Syst. Rev. 2009;CD001877 doi:10.1002/14651858.CD001877.pub3
Overdiagnosis bias
Gigerenzer G, et al. Helping doctors and patients make sense of health statistics. Psychological Science in the Public Interest 2008;8(2):53-96.
Evaluating Screening Tests
Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:88-94
18
Can We Trust Guidelines from Specialty Societies?
Or
Never ask a barber if you need a haircut
“. . . The guild of health care professionals – including their specialty societies – has a primary responsibility to promote its members’ interests. . .
Quanstrum KH, Hayward RA. Lessons from the mammography wars. N Engl J Med 2010; 363:1076-1079
19
. . . It is a fool’s dream to expect the guild of any service industry to harness its self-interest and to act according to beneficence alone – to compete on true value when the opportunity to inflate perceived value is readily available.”
Quanstrum KH, Hayward RA. Lessons from the mammography wars. N Engl J Med 2010; 363:1076-1079
20
Screening for breast cancer: yearly at age 40
American College of Radiology Society of Breast Imaging American Society of Breast Disease American Cancer Society ACOG
“Evidence-based” and the evolution of evidence: subclinical hypothyroidism
Step 1 Search of 10 databases Studies summarized 12 experts rated the evidence Recommendations:
• “Recommend against routine screening for subclinical hypothyroidism”
• “Recommend against routine treatment of 4.5 – 10.0 mIU/L”
Surks MI, et al. Subclinical thyroid disease. Scientific Review and Guidelines for diagnosis and management. JAMA 2004;291:228-238.
“Evidence-based” and the evolution of evidence: subclinical hypothyroidism
Step 2: Consensus meeting among members of the American Association of
Clinical Endocrinologists, The American Thyroid Association, and The
Endocrine Society.
New recommendation statement
Recommendations sent to leadership of the organizations
The evolution of evidence: subclinical hypothyroidism
The result: New recommendations from the three societies:
• Most patients with TSH levels 4.5 – 10 mIU/L should be treated• Shouldperform routine screening for subclinical hypothyroidism
Why?• “Although good evidence is unavailable [to support our
recommendation], there is a sizable amount of fair evidence and an abundance of opinion by experts . . . The [scientific panel recommendations] are contrary to the practice of many. . . experts”
Gharib H, et al. Consensus statement: Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, The American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005;90:581-5.
Bilirubin in term infants (Sept 2009)
USPSTF: Summary of Recommendation“The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend screening infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy”
American Academy of Pediatrics Restatement and Clarification“. . .We recommend universal predischarge bilirubin screening,which helps to assess the risk of subsequent severehyperbilirubinemia. We also recommend a more structured approachto management and follow-up according to the predischarge TSB/TcB,gestational age, and other risk factors for hyperbilirubinemia.These recommendations represent a consensus of expert opinionbased on the available evidence, and they are supported by severalindependent reviewers. Nevertheless, their efficacy in preventingkernicterus and their cost-effectiveness are unknown. “
Evidence Linked Guidelines
Brief Summary Statement for each recommendation
Detailed Discussion of the evidence Long Reference section pointing to original
research Methods section showing how evidence was
obtained and evaluated
Evidence Linked Guidelines
Brief s
tatementDetailed overview of the evidence
Evidence table
28
National Guideline Clearinghouse
www.ngc.gov Vetted guidelines from various groups Standard organization so that information can be
compared across various guidelines